semaglutide injection spot How to Treat a Site Reaction Red bump/mark at injection site?

National Institutes of Health (NIH) PubMed: Study on the heart rate effects of GLP 1 receptor agonists

It is essential to establish extensive, multicenter randomised studies to evaluate GLP-1 receptor agonists in women undergoing reproductive therapy

Dosing and Administration: What to Expect Zepbound Dosing Schedule Zepbound is administered as a once-weekly subcutaneous injection: Weeks 1-4: 2.5 mg once weekly Weeks 5-8: 5 mg once weekly Weeks 9+: Increase by 2.5 mg every 4 weeks as tolerated Maintenance Dose: 5 mg, 10 mg, or 15 mg once weekly Most patients in clinical trials (89.3%) reached the maximum 15 mg dose, demonstrating good tolerability with gradual escalation

Separate clinical studies suggest similar weight loss results for both forms, but the studies were not designed as a head-to-head comparison